When Amy Cohen, 29, finished the New York City Marathon, she broke ground as the first person with the illness to run the ...

“I told God, ‘I don’t think it’s time yet. I don’t feel like I did enough for you,’” she recalled. A pastor’s wife later ...

Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the company will present updated safety and efficacy ...

Go to or scan the QR code and use code LIST to get your free FM Topper when you order your Journey Pack today. WATCH OUR ...

Smith, a microbiologist whose discovery revolutionize the field of genetic engineering, was a Johns Hopkins School of ...

A cutting-edge medical experiment in a small trial has demonstrated the effectiveness of a one-time CRISPR gene editing treatment in lowering cholesterol levels ...

The first sickle cell disease patient has been enrolled in a Phase 1b trial testing iadademstat, Oryzon Genomics' ...

Sanofi's Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia Recommendation based on LUNA 3 phase 3 study demonstrating rapid and durable platelet response and significant ...

They’ve now developed a groundbreaking ultrasound technology that can measure this key property non-invasively and in real ...

Pain is a constant, complex companion that clinicians often struggle to understand and measure for people living with sickle ...

Scientists at St. Jude Children's Research Hospital and Northwestern University identified a previously unknown treatment ...